Atlas Energy Corp. (CANSD)
OTCMKTS
· Delayed Price · Currency is USD
0.1611
+0.0113 (7.57%)
At close: Jun 24, 2025
Atlas Energy Revenue
Atlas Energy had revenue of 1.76M CAD in the quarter ending March 31, 2025, with 3,349.02% growth. This brings the company's revenue in the last twelve months to 6.37M, up 571.23% year-over-year. In the year 2024, Atlas Energy had annual revenue of 4.66M with 297.78% growth.
Revenue (ttm)
6.37M CAD
Revenue Growth
+571.23%
P/S Ratio
1.53
Revenue / Employee
335.26K CAD
Employees
19
Market Cap
6.77M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.66M | 3.49M | 297.78% |
Dec 31, 2023 | 1.17M | 351.00K | 42.75% |
Dec 31, 2022 | 821.00K | 688.00K | 517.29% |
Dec 31, 2021 | 133.00K | 123.00K | 1,230.00% |
Dec 31, 2020 | 10.00K | 5.00K | 100.00% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Federal National Mortgage Association | 30.44B |
Federal Home Loan Mortgage | 23.43B |
Jingbo Technology | 2.14M |
Alpine Auto Brokers | 129.78K |
First National of Nebraska | 1.89B |
Mechanics Bank | 381.61M |
Wilson Bank Holding Company | 189.72M |
Endo, Inc. | 1.73B |
Atlas Energy News
- 6 weeks ago - WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS - PRNewsWire
- 7 weeks ago - WILLOW BIOSCIENCES INC. ANNOUNCES COMPLETION OF SALE OF OPERATING SUBSIDIARY AND MANAGEMENT CHANGES - PRNewsWire
- 2 months ago - WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS - PRNewsWire
- 3 months ago - WILLOW BIOSCIENCES REPORTS 2024 FINANCIAL RESULTS AND UPDATE REGARDING SALE OF OPERATING SUBSIDIARY - PRNewsWire
- 5 months ago - WILLOW ANNOUNCES INITIATION OF STRATEGIC REVIEW PROCESS - PRNewsWire
- 8 months ago - WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 8 months ago - WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIO - PRNewsWire
- 9 months ago - WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT - PRNewsWire